← Back to all stories
HealthScienceDaily: Avocado lowers heart disease risk

Daily avocado intake modestly lowers LDL particle levels linked to heart disease risk in adults with obesity

A Penn State-led ancillary analysis of a randomized trial found that adults with abdominal obesity who ate one avocado daily for six months reduced blood concentrations of LDL particles by about 49 nmol/L compared with those on their habitual diet. Researchers estimated this change corresponds to an approximate 4% lower heart disease risk, with no significant effects on weight or other lipoprotein measures.

Key points

  • One avocado daily for 26 weeks cut LDL particle concentration by 49.1 nmol/L in adults with obesity.
  • Change linked to roughly 4% lower estimated heart disease risk; no weight loss observed.
  • Benefit consistent across sex, age, race, ethnicity, and BMI in the 786-participant analysis.
3h ago2 min read5 SourcesAI-generated — how does this work?

Why this is uncovered

Covered by university releases, ScienceDaily, EurekAlert, MedicalXpress and some local TV, with limited national mainstream pickup.


This article was generated automatically from primary sources and has not been reviewed by a human editor. Verify claims before sharing.

Eating one avocado per day for six months modestly reduced concentrations of low-density lipoprotein (LDL) particles in the blood of adults with abdominal obesity, according to a new analysis led by researchers at Penn State. The reduction corresponded to an estimated 4% lower risk of heart disease, the team reported.

The findings come from an ancillary study of the Habitual Diet and Avocado Trial, a multicenter randomized controlled trial. Results were published in the Journal of Clinical Lipidology (doi.org/10.1016/j.jacl.2026.06.005). The analysis examined data from 786 participants (74% female; average age 51 years; average BMI 32.9) who had abdominal obesity, defined as waist circumference greater than 40 inches for men or 35 inches for women (psu.edu).

Participants were randomly assigned to either continue their usual diet and activity or to add one Hass avocado (approximately 168 g) daily while otherwise maintaining their normal routines. No other dietary counseling was provided. Blood samples collected at baseline and after 26 weeks were analyzed using nuclear magnetic resonance spectroscopy for lipoprotein particles and subclasses.

Those in the avocado group showed a mean reduction in total LDL particle concentration of 49.1 nmol/L (95% CI: −83.6 to −14.5; P = .005) compared with the habitual-diet group (lipidjournal.com). Researchers noted that this magnitude of change is associated with an approximate 4% reduction in cardiovascular disease risk. No significant between-group differences appeared for LDL particle size or subclasses, triglyceride-rich lipoprotein particles, high-density lipoprotein particles, or apolipoproteins A or B.

Earlier results from the same trial had shown that daily avocado intake did not change body weight or waist circumference but produced a modest reduction in LDL cholesterol. The current analysis focused on particle number, a measure that can indicate elevated risk even when LDL cholesterol levels appear similar, because smaller or more numerous particles more readily contribute to arterial plaque (sciencedaily.com).

“If people want to improve the quality of their diet, making one small change might be a more feasible strategy than attempting to change their entire diet,” said first author Janhavi Damani, a postdoctoral scholar at Penn State. Senior author Kristina Petersen, associate professor of nutritional sciences, noted that earlier controlled-feeding studies had shown similar benefits, but this trial demonstrated effects under free-living conditions where diets are less predictable (eurekalert.org).

The LDL-particle reduction was consistent across participants regardless of sex, race, ethnicity, age, or body mass index. The Avocado Nutrition Center supported the research. Investigators advised that individuals consult a registered dietitian or physician for personalized dietary guidance. The original Habitual Diet and Avocado Trial is registered at clinicaltrials.gov (NCT03528031).

Share:X / TwitterLinkedIn

More in Health

Houston Methodist study identifies fat molecule linking obesity to Alzheimer's progression

Researchers at Houston Methodist have found that obesity elevates levels of phosphatidylethanolamines (PEs), fat molecules that travel to the brain, disrupt immune defenses, and promote amyloid buildup associated with Alzheimer's disease. Restoring PE balance in disease models improved cognitive function. The findings, published in Molecular Neurodegeneration, suggest a potential therapeutic target for metabolically at-risk individuals.

31 Jul 2026

Daily multivitamin linked to better daily functioning in adults over 60

A secondary analysis of the large COSMOS randomized trial found that older adults taking a daily multivitamin for three years reported better functional health scores than those on placebo. The modest improvements, measured by a validated questionnaire on symptom burden and physical ability, were presented at the American Society for Nutrition’s NUTRITION 2026 meeting. Researchers noted the findings are preliminary pending peer-reviewed publication.

30 Jul 2026

ECDC warns longer warmer summers raise infectious disease risks across Europe

The European Centre for Disease Prevention and Control (ECDC) said longer and warmer summers are increasing risks of foodborne illnesses, vibriosis, mosquito-borne diseases and tick-borne infections. The agency called for stronger cross-border and cross-sector cooperation under a One Health approach, noting that while many EU states have climate adaptation plans, dedicated public health measures for extreme weather need strengthening.

30 Jul 2026